K.M. de Bruijn

704 total citations
23 papers, 540 citations indexed

About

K.M. de Bruijn is a scholar working on Surgery, Pathology and Forensic Medicine and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, K.M. de Bruijn has authored 23 papers receiving a total of 540 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Surgery, 7 papers in Pathology and Forensic Medicine and 5 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in K.M. de Bruijn's work include Nausea and vomiting management (13 papers), Chemotherapy-induced organ toxicity mitigation (7 papers) and Pharmacological Effects and Toxicity Studies (5 papers). K.M. de Bruijn is often cited by papers focused on Nausea and vomiting management (13 papers), Chemotherapy-induced organ toxicity mitigation (7 papers) and Pharmacological Effects and Toxicity Studies (5 papers). K.M. de Bruijn collaborates with scholars based in Netherlands, United Kingdom and Switzerland. K.M. de Bruijn's co-authors include Laurence M. Blendis, Paula Pitt, I. J. Klompmaker, Bengt Sorbe, G. Harvey Anderson, Peter L. Carlen, D. H. Zilm, A. Himmelmann, Thomas Högberg and Guido G. Persijn and has published in prestigious journals such as The Lancet, Cancer and Gut.

In The Last Decade

K.M. de Bruijn

23 papers receiving 492 citations

Peers

Countries citing papers authored by K.M. de Bruijn

Since Specialization

Citations

This map shows the geographic impact of K.M. de Bruijn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K.M. de Bruijn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K.M. de Bruijn more than expected).

Fields of papers citing papers by K.M. de Bruijn

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K.M. de Bruijn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K.M. de Bruijn. The network helps show where K.M. de Bruijn may publish in the future.

Co-authorship network of co-authors of K.M. de Bruijn

This figure shows the co-authorship network connecting the top 25 collaborators of K.M. de Bruijn. A scholar is included among the top collaborators of K.M. de Bruijn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K.M. de Bruijn. K.M. de Bruijn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A randomized, double-blind, multicentre study comparing daily 2 and 5 mg of tropisetron for the control of nausea and vomiting induced by low-dose cisplatin- or non-cisplatin-containing chemotherapy 1996 ·Annals of Oncology ·A.N.M. Wymenga, Winette T.A. van der Graaf, J. Wils, (unknown), George Linden, (unknown), M A Nooy, C. Van Der Heul, K.M. de Bruijn, Elisabeth G.E. de Vries	5
2	Hypersensitivity reactions associated with 5-hydroxytryptamine3-receptor antagonists: a class effect? 1996 ·The Lancet ·Vesa Kataja, K.M. de Bruijn	10
3	Tropisetron alone or in combination with dexamethasone for the prevention and treatment of emesis induced by non-cisplatin chemotherapy 1995 ·Anti-Cancer Drugs ·Malcolm Adams, M. Soukop, V. Barley, H. Yosef, (unknown), (unknown), C Trask, (unknown), K.M. de Bruijn	13
4	Is Navoban® (tropisetron) as effective as Zofran® (ondansetron) in cisplatin-induced emesis? 1995 ·Anti-Cancer Drugs ·Michel Marty, (unknown), P. Fournel, A. Vergnenègre, Pierre Carlès, (unknown), (unknown), K.M. de Bruijn	26
5	Tropisetron compared with a metoclopramide-based regimen in the prevention of chemotherapy-induced nausea and vomiting 1994 ·European Journal of Cancer ·(unknown), N. Thatcher, Anthony Howell, Keiran Logan, (unknown), K.M. de Bruijn	11
6	A randomized, multicenter study comparing the efficacy and tolerability of tropisetron, a new 5-HT3 receptor antagonist, with a metoclopramide-containing antiemetic cocktail in the prevention of cisplatin-induced emesis 1994 ·Cancer ·Bengt Sorbe, Thomas Högberg, Bengt Glimelius, (unknown), (unknown), Olfred Hansen, (unknown), (unknown), A.T. van Oosterom, K.M. de Bruijn	35
7	Efficacy and tolerability of tropisetron in comparison with a combination of tropisetron and dexamethasone in the control of nausea and vomiting induced by cisplatin-containing chemotherapy 1994 ·European Journal of Cancer ·Bengt Sorbe, Thomas Högberg, A. Himmelmann, (unknown), (unknown), (unknown), K.M. de Bruijn	30
8	Dose-finding study of tropisetron in cisplatin-induced nausea and vomiting 1994 ·Annals of Oncology ·(unknown), (unknown), Harry Bleiberg, V. Cocquyt, J. Michel, K.M. de Bruijn	13
9	Safety, tolerability, efficacy and plasma concentrations of tropisetron after administration at five dose levels to children receiving cancer chemotherapy 1994 ·European Journal of Cancer ·A. Suarez, (unknown), (unknown), Guillem Pons, (unknown), K.M. de Bruijn, G Olivé, J Lemerle	18
10	Efficacy and tolerability of tropisetron and dexamethasone in the control of nausea and vomiting induced by cisplatin 1993 ·Annals of Oncology ·(unknown), Bengt Sorbe, Thomas Högberg, A. Himmelmann, (unknown), (unknown), K.M. de Bruijn	24
11	The development of tropisetron in its clinical perspective 1993 ·Annals of Oncology ·K.M. de Bruijn	16
12	TROPISETRON FOR POSTOPERATIVE NAUSEA AND VOMITING IN PATIENTS AFTER GYNAECOLOGICAL SURGERY 1993 ·British Journal of Anaesthesia ·(unknown), (unknown), K.M. de Bruijn	40
13	Methodology of Antiemetic Trials 1992 ·Drugs ·J. Gordon McVie, K.M. de Bruijn	4
14	Tropisetron 1992 ·Drugs ·K.M. de Bruijn	68
15	Recurrence of hepatocellular carcinoma after liver retransplantation 1988 ·BMJ ·I. J. Klompmaker, K.M. de Bruijn, Annette Gouw, (unknown), (unknown)	5
16	Prophylaxis with ranitidine against peptic ulcer disease after liver transplantation 1988 ·Transplant International ·I. J. Klompmaker, M. J. H. Slooff, K.M. de Bruijn, (unknown), (unknown)	7
17	Mortality after orthotopic liver transplantation: An analysis of the causes of death in the first 50 liver transplantations in Groningen, The Netherlands 1988 ·Transplant International ·M. J. H. Slooff, I. J. Klompmaker, (unknown), K.M. de Bruijn, R. Verwer, E. J. Hesselink, Elizabeth B. Haagsma	3
18	Clinical and experimental studies on ammonia metabolism and treatment forms of portal-systemic encephalopathy 1986 ·K.M. de Bruijn	1
19	Effect of dietary protein manipulation in subclinical portal-systemic encephalopathy. 1983 ·Gut ·K.M. de Bruijn, Laurence M. Blendis, D. H. Zilm, Peter L. Carlen, G. Harvey Anderson	51
20	Studies on breath methane: the effect of ethnic origins and lactulose. 1980 ·Gut ·Paula Pitt, K.M. de Bruijn, (unknown), (unknown), Laurence M. Blendis	103

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact